Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
Abstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a m...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Health & Justice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40352-020-0106-9 |
id |
doaj-984323bde8bf45649f1bc4731bcab1e3 |
---|---|
record_format |
Article |
spelling |
doaj-984323bde8bf45649f1bc4731bcab1e32020-11-25T02:51:12ZengBMCHealth & Justice2194-78992020-03-018111010.1186/s40352-020-0106-9Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participationJordan M. Hyatt0Philipp P. Lobmaier1Department of Criminology and Justice Studies, Drexel UniversityNorwegian Centre for Addiction Research, University of OsloAbstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a marked increase in the number of drug courts, prisons and agencies in which MAT, notably with long-acting injectable medications, is offered. While this is a positive development, ensuring that vulnerable individuals are in a position voluntarily participation within the complex criminal justice environment is necessary. The unequal authority and agency inherent in the nature of these environments should be recognized. Therefore, rigorous protections, mirroring the goals of the consent processes required for medical or sociobehavorial research, should be employed when MAT is offered to protect individual autonomy.http://link.springer.com/article/10.1186/s40352-020-0106-9Medication-assisted treatment (MAT)Opioid abuseCorrectionsDrug addictionInformed consentCoercion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jordan M. Hyatt Philipp P. Lobmaier |
spellingShingle |
Jordan M. Hyatt Philipp P. Lobmaier Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation Health & Justice Medication-assisted treatment (MAT) Opioid abuse Corrections Drug addiction Informed consent Coercion |
author_facet |
Jordan M. Hyatt Philipp P. Lobmaier |
author_sort |
Jordan M. Hyatt |
title |
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
title_short |
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
title_full |
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
title_fullStr |
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
title_full_unstemmed |
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
title_sort |
medication assisted treatment (mat) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation |
publisher |
BMC |
series |
Health & Justice |
issn |
2194-7899 |
publishDate |
2020-03-01 |
description |
Abstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a marked increase in the number of drug courts, prisons and agencies in which MAT, notably with long-acting injectable medications, is offered. While this is a positive development, ensuring that vulnerable individuals are in a position voluntarily participation within the complex criminal justice environment is necessary. The unequal authority and agency inherent in the nature of these environments should be recognized. Therefore, rigorous protections, mirroring the goals of the consent processes required for medical or sociobehavorial research, should be employed when MAT is offered to protect individual autonomy. |
topic |
Medication-assisted treatment (MAT) Opioid abuse Corrections Drug addiction Informed consent Coercion |
url |
http://link.springer.com/article/10.1186/s40352-020-0106-9 |
work_keys_str_mv |
AT jordanmhyatt medicationassistedtreatmentmatincriminaljusticesettingsasadoubleedgedswordbalancingnoveladdictiontreatmentsandvoluntaryparticipation AT philippplobmaier medicationassistedtreatmentmatincriminaljusticesettingsasadoubleedgedswordbalancingnoveladdictiontreatmentsandvoluntaryparticipation |
_version_ |
1724735724921552896 |